INTRODUCTION
The selectin family of cell adhesion molecules comprising P-, L-and E-selectin and their glycoconjugate ligands play an important role in the initial events of the inflammatory cascade, by initiating the tethering and rolling of circulating leukocytes on endothelial cells, platelets, and other leukocytes (1). Selectins bind with high affinity to specific macromolecular ligands in the vascular system containing the sialyl Lewis x epitope (sLe x1 , NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAc-R), but binding to the sLe x -containing glycan alone is weak (2, 3) . The best characterized ligand for selectins is P-selectin glycoprotein ligand-1 (PSGL-1), a disulfide-linked homodimeric mucin on leukocytes. PSGL-1 binds with relatively high affinity (K d~3 00 nM) to P-selectin (4) . By contrast, L-selectin binds to the sulfated mucin GlyCAM-1 with a K d of ~108
µM (5) and E-selectin binds to ESL-1 with a K d of 62 µM (6).
The extreme N-terminus of mature human PSGL-1 begins at amino acid residue 42 and contains three potential tyrosine sulfation sites at Tyr46, -48 and -51. Sulfation of these tyrosine residues, along with a core-2 O-glycan capped with sLe x (C2-O-sLe x ) at Thr57, are necessary for high affinity binding of PSGL-1 to P-selectin (7) (8) (9) (10) . Direct interaction of P-selectin with this domain was demonstrated by utilizing synthetic glycosulfopeptides. Monomeric glycosulfopeptide-6 (1-GSP-6), corresponding to an N-terminal segment of PSGL-1 containing three TyrSO 3 -residues at Tyr46, -48 and -51 and a C2-O-sLe x at Thr57, binds to P-selectin with
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Thr residues (7) . Endo-β-galactosidase treatment of PSGL-1 from human neutrophils suggested that PSGL-1 carries sialylated and fucosylated polylactosamines [-3Galβ1-4GlcNAcβ1-] n in Oglycans that promote high affinity binding to P-selectin (13) . Subsequent detailed structural analysis of O-glycans on PSGL-1 from the human promyelocytic cell line HL-60 showed that a majority of the fucose-containing O-glycans on PSGL-1 from HL-60 cells were sialylated and polyfucosylated polylactosamines (PFPL) (10) . Surprisingly, however, only 14% of the total Oglycans in PSGL-1 from HL-60 cells were α1,3-fucosylated and contained sLe x (10) . Two fucosylated O-glycans were identified: a core-2 based monosialylated, trifucosylated structure with a polylactosamine backbone (C2-O-Le x -Le x -sLe x , 12%), and a less abundant core-2 based disialylated, monofucosylated structure lacking polylactosamine (C2-O-sLe x , 2%). While synthetic glycosulfopeptides containing the simple monosialylated monofucosylated C2-O-sLe x bind to P-selectin, the role of sialylated PFPL O-glycans in binding to P-selectin has not been studied. Efficient generation of sialylated PFPL in vitro requires the participation of two human α1,3-fucosyltransferases expressed in leukocytes -FucT-IV and FucT-VII (14, 15) . FucT-IV appears to preferentially fucosylate internal GlcNAc residues within the polylactosamine backbone, whereas FucT-VII fucosylates a GlcNAc residue of the non-reducing sialylated Nacetyllactosamine unit to generate the sLe x terminus (14) . Studies in mice containing null mutations in FucT-VII or in both FucT-IV and FucT-VII have led support to the possibility that both enzymes contribute to selectin ligands, possibly by cooperating to generate the sialylated PFPL (16) (17) (18) .
To gain direct insight into the contribution of O-glycans with extended polylactosamine in PSGL-1 for binding to P-selectin, we synthesized two novel GSPs corresponding to the Nterminal amino acid sequence of human PSGL-1. These contained the sLe x epitope on an 6 extended core-2 based O-glycan at Thr57 with either two (C2-O-Le x -sLe x ) or three (C2-O-Le xLe x -sLe x ) fucosylated lactosamine repeats, plus three TyrSO 3 -residues at Tyr46, -48 and -51
( Fig. 1 ). Using these synthetic GSPs we directly examined the contribution of the extended Oglycan for binding to P-selectin.
EXPERIMENTAL PROCEDURES
Enzymatic synthesis of GSP-6' and GSP-6": Approach I (see Fig. 2A ) -Glycopeptide-1 (GP-1) corresponding to amino acid residues 45-61 of human PSGL-1 with a GalNAcα residue at T57 was synthesized on an automated peptide synthesizer as described (19) . In Approach I reversed phase HPLC-purified GP-1 served as an acceptor for enzymatic synthesis of GSP-6' and GSP-6". GP-4 was synthesized and purified as described (11, 19) . GP-4 was extended using partially purified β1,3-GlcNAcT from human serum (precipitated from human serum by ammonium sulfate at 25-50 % saturation) (20) . In a typical reaction, GP-4 (20 nmol), UDPGlcNAc (560 nmol), MnCl 2 (160 nmol), 0.04 % (w/v) NaN 3 and a concentrate of β1,3-GlcNAcT (700 µg protein) were incubated for nine days at 37 o C in 20 µl of 50 mM Tris-HCl, pH 7.5. Then 100 µl of 50 mM NH 4 HCO 3 was added, the solution was clarified by centrifugation, and the clear supernatant was subjected to gel filtration HPLC on a column of Superdex 75 HR (Pharmacia, Uppsala, Sweden). The glycopeptide fraction was analyzed by MALDI mass spectrometry (MS) as described (11 ion of GP-6" (calc. m/z 4489.1). MALDI analysis showed that partially fucosylated structures were very minor but the signal of anhydro-GP-6" was ~50 %. Glycopeptide products GP-6' and GP-6" were further purified in reversed phase HPLC where GP-6' and GP-6" were separated from anhydro-GP-6' and -GP-6", respectively. The masses of GP-6' and GP-6" were verified by electrospray MS which showed the molecular masses of 3977.8 for GP-6' and 4489.1 for GP-6".
Sodium adducts of the peptides were also present in the mass spectra. Glycopeptides GP-6' and GP-6" were sulfated enzymatically using human tyrosyl-protein sulfotransferase-1 and
]PAPS (1470 cpm/pmol) (NEN Life Science Products, Inc. Boston, MA) as a sulfate donor as described (11) . The fully sulfated glycosulfopeptides, GSP-6' and GSP-6" were separated from partially sulfated glycosulfopeptides using HPLC.
Enzymatic synthesis of GSP-6' and GSP-6": Approach II (see Fig. 2B ) -Glycosulfopeptide-1 (GSP-1), corresponding to amino acid residues 45-61 of human PSGL-1 with three TyrSO 3 residues (Y46, 48 and 51) and a GalNAcα residue at T57, was synthesized on an automated peptide synthesizer as described (19) . HPLC-purified GSP-1 served as an acceptor for enzymatic synthesis of GSP-6' and GSP-6". The glycosyltransferase reactions were carried out by adding one glycosyltransferase and one donor at a time, and the completeness of each reaction was followed by HPLC. After the reaction was 95-100 % complete, a new glycosyltransferase and a new donor were added. The first steps in the synthesis have been described in detail (11, 19) . Briefly, the GalNAc residue in GSP-1 served as an acceptor for core- was divided into two. One half was treated with neuraminidase as described below, and the other half was extended by one N-acetyllactosamine unit using (Nm)β1,3-GlcNAcT and β1,4-GalT.
The resulting GSP-4S.4 was treated with neuraminidase. The neuraminidase-treated samples (GSP-4.2 and GSP-4.4, 40-50 nmol each) were purified by HPLC and sialylated for ~40 h at 37ºC using 500 nmol of CMP-NeuAc and 80 mU of α2,3-(N)-sialylT (Calbiochem) in a total reaction volume of 500 µl of 50 mM Na-cacodylate, pH 7.4 containing 15 mM MnCl 2 , 0.5 mg/ml BSA and 1U alkaline phosphatase. The newly sialylated samples were divided into two.
One half of the reaction mixture containing GSP-5' or GSP-5" was purified by HPLC and analyzed by MS. The other half was fucosylated for ~21 h at 37ºC using 3 times molar excess of GDPFuc and 10 mU of α1,3-FucTVI (Calbiochem). The reaction products (GSP-6' and GSP-6") Fig. 2 were also verified by MS (data not shown). The enzymatic synthesis of GSP-6 and GP-6 has been described earlier (19) .
Radiolabeled glyco(sulfo)peptides were synthesized using GP-5, GSP-5, GSP-5' and GSP-5" as acceptors and GDP-[ Reactions were terminated by boiling for 5 min. The samples were filtered through a Spin-X membrane, purified by HPLC, and analyzed by electrospray MS.
were desialylated using 2 mU of neuraminidase and purified by HPLC.
P-selectin affinity chromatography -Soluble P-selectin (sPS) was coupled to Ultralink
Biosupport Medium (Pierce, Rockford, IL) at a density of 2 mg/ml. Radiolabeled glyco(sulfo)peptides (~2000 cpm, 0.3-1 pmol) were chromatographed in the sPS column (0.9 ml, 0.5 x 4.5 cm) using physiological salt concentration (20 mM MOPS, pH 7.5, containing 150 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 0.02 % NaN 3 ) as described (19) .
Equilibrium gel filtration chromatography -Hummel-Dreyer equilibrium gel filtration experiments (23, 24) were conducted in a 2 ml Sephadex G-100 column (0.5 x 10 cm) at a subphysiological salt concentration (20 mM MOPS, pH 7.5, containing 50 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 0.02 % NaN 3 ) as described (11 
Pronase digestion of GP-6 -[ 3 H]GP-6 (6330 cpm/pmol) was digested with
Streptomyces griseus pronase E (2 mg/ml) (Sigma, St. Louis, MO) as described (19) . Mass spectrometric analysis of glyco(sulfo)peptides -Electrospray mass spectra were collected in the negative ion mode using a Q-STAR triple-quadrupole MS (PerkinElmer Sciex Instruments, Thornhill, Ontario, Canada). Samples were dissolved in 10 mM ammonium acetate in 50 % aqueous acetonitrile to a concentration of ~2 pmol/µl and injected into the MS with a nanoelectrospray ion source.
Biotinylation of glyco(sulfo)peptides -
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RESULTS
Synthesis of glycosulfopeptides with sialylated and PFPL O-glycan -To define the
possible contributions of sialylated PFPL O-glycan for binding of PSGL-1 to P-selectin, we synthesized glyco(sulfo)peptides (GSPs) corresponding to the N-terminal amino acid residues 45-61 of human PSGL-1 (Fig. 1) . All sulfated GSPs contained three TyrSO 3 -residues at Tyr46, 48 and 51, whereas some control peptides were not sulfated (GP-6 and GP-4). GSP-6 and GP-6 contained simple C2-O-sLe x at Thr57, whereas GSP-6' and GSP-6" contained two (C2-O-Le xsLe x ) or three (C2-O-Le x -Le x -sLe x ) fucosylated lactosamine repeats at Thr57, respectively.
Desialylated GSP-6' and GSP-6" were prepared by treating GSP-6' and GSP-6" by neuraminidase. GSP-5' and GSP-5" were nonfucosylated derivatives of GSP-6' and GSP-6", respectively. Incompletely glycosylated GSP-1 and GP-4 contained a GalNAc residue only or galactosylated core-2 tetrasaccharide at Thr57, respectively (Fig. 1) .
Glyco(sulfo)peptides GSP-6 and GP-6 lacking polylactosamine sequences were synthesized as described (19) . Sialylated PFPL O-glycans of GSP-6' and GSP-6" were synthesized using two different approaches (Fig. 2) . In Approach I, nonsulfated GP-1 with an α-linked GalNAc at Thr57 was synthesized on an automated peptide synthesizer as described (19) .
GP-1 served as an initial acceptor for further glycosylation with purified or recombinant glycosyltransferases ( Fig. 2A) . The galactosylated core-2 branch of GP-4 was an acceptor site for the polylactosamine extension enzyme from human serum, (hs)β1,3-GlcNAcT. The alternating action of (hs)β1,3-GlcNAcT and β1,4GalT yielded nonsulfated glycopeptides with two (GP-4.2) or three (GP-4.4) polylactosamine repeats. GP-4.2 and GP-4.4 were further α2,3-sialylated and α1,3-fucosylated, and the resulting nonsulfated glycopeptides GP-6' and GP-6"
were purified by reversed phase HPLC and characterized by electrospray MS. Tyrosine residues 15 of GP-6' and GP-6" were enzymatically sulfated using recombinant human TPST-1 and
Trisulfated radiolabeled glycosulfopeptides GSP-6' and GSP-6" were isolated and purified by HPLC (not shown).
In Approach II TyrSO 3 -residues were incorporated into the peptide during the solidphase peptide synthesis (19) . GSP-1 served as an initial acceptor for glycosyltransferases ( 
GSPs with sialylated PFPL O-glycan have impaired affinity for immobilized P-selectin
-We initially tested binding of GSP-6' and GSP-6" to P-selectin by affinity chromatography of radiolabeled GSPs on immobilized soluble P-selectin (sPS) at physiological salt concentration
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(150 mM NaCl). GSP-6' and GSP-6" did not detectably interact with immobilized sPS, whereas the control compound GSP-6 bound to immobilized sPS (Fig. 3) . These results indicate that sLe x presented on an extended fucosylated polylactosamine O-glycan, as in GSP-6' and GSP-6", decreases binding of glycosulfopeptides to P-selectin.
The affinity of P-selectin to GSP-6' and GSP-6" is similar to the affinity of P-selectin to GP-6 -Selectins bind to their ligands with higher affinity at subphysiological salt concentration than at physiological salt concentration (26) . Therefore, the binding affinities of GSPs that show weak or no interaction to P-selectin at physiological salt concentration can be estimated relative to a "standard" glycopeptide at subphysiological salt concentration (19) . To define whether there are weak interactions of GSP-6' and GSP-6" with P-selectin, we developed a sensitive fluorescence-based solid phase assay. Equimolar amounts of biotinylated glyco(sulfo)peptides were first captured quantitatively on Streptavidin-coated 96-well plates. P-selectin-Ig chimera (P-sel-Ig) was incubated with the wells, and bound P-sel-Ig was detected with fluorescently labeled anti-human IgG. To confirm equal capture of each biotinylated GSP, we measured the binding of monoclonal antibody PL1, which recognizes a peptide epitope in PSGL-1 that is also present in the GSPs (25) . The fluorescence assay was performed under reduced salt concentration (50 mM NaCl) to enhance the binding of relatively weak ligands. P-sel-Ig showed high affinity binding to GSP-6; binding increased with a linear correlation to increased concentrations of P-sel-Ig chimera (Fig. 4A) . P-sel-Ig showed linear, but much weaker, binding to GSP-6' and GSP-6". The binding of P-sel-Ig to GSP-6' and GSP-6" was similar to the binding of P-sel-Ig to the nonsulfated GP-6 (Fig. 4A) . P-sel-Ig did not detectably bind to the non-sulfated GP-4, which also lacks fucose and sialic acid. The coating with each GSP was in a similar range, as determined by binding of PL1 (Fig. 4B) . The results indicate that P-selectin binds with significantly lower affinity to GSP-6' and GSP-6" than to GSP-6.
The binding of P-selectin to GSP-6' and GSP-6" is Ca 2 + -dependent and partially
dependent on α2,3-sialic acid, α1,3-fucose and the sulfated peptide backbone -The relative contributions of Ca 2+ , sialic acid, and fucose for binding of GSP-6' and GSP-6"to P-selectin was next examined. A fixed concentration of P-sel-Ig (3 µg/ml) was incubated with a series of immobilized glyco(sulfo)peptides (Fig. 5A ) Similar amounts of mAb PL1 bound to each peptide, demonstrating that the peptides were immobilized at equivalent densities (Fig. 5B ). GP-6 was used as a reference peptide, because the dissociation constant for its binding to P-selectin (K d 3
.1 µM, see below) was determined using equilibrium gel filtration under subphysiological salt concentration. P-sel-Ig bound equally well to GSP-6" and the non-sulfated GP-6, whereas P-selIg bound ~2 times better to GSP-6' (Fig. 5A) . Desialylation of GSP-6' by neuraminidase treatment reduced its binding to P-sel-Ig by ~50%, whereas desialylation of GSP-6" did not affect its binding (Fig. 5A) . As a result P-sel-Ig bound equally to desialylated GSP-6' and GSP-6"; thus, the sialic acid of GSP-6', but not of GSP-6", contributes to its weak binding.
P-sel-Ig bound equally to the sialylated but non-fucosylated GSP-5' and GSP-5"; this binding was weaker than to desialylated GSP-6' and GSP-6". These results indicate that fucose contributes more than sialic acid to binding of GSP-6' and GSP-6" to P-selectin. The binding of P-sel-Ig to GSPs was only partially inhibited by EDTA (Fig. 5A ). This observation suggests that Ca 2+ -independent residual binding of P-sel-Ig to GSP-6' and GSP-6" and to their desialylated and defucosylated derivatives is through recognition of the sulfated peptide backbone rather than the polylactosamine O-glycan. The binding of P-sel-Ig to the nonsulfated GP-6 was completely
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inhibited by EDTA, demonstrating that the binding of P-sel-Ig to the sLe x -containing O-glycan is strictly Ca 2+ dependent.
GSP-6' and GSP-6" have 50-80 -fold impaired affinity for P-selectin in comparison to
GSP-6. Lowering the NaCl concentration from 150 mM to 50 mM increases the binding affinity of GSP-6 to sPS by 9-fold (19) . Therefore, the binding affinities of GSPs that show weak or no interaction to immobilized P-selectin at physiological salt can be estimated relative to known "standard" glyco(sulfo)peptides at subphysiological salt in equilibrium gel filtration. We used nonsulfated GP-6 as a reference glycopeptide, because the fluorescence-based solid phase assay indicated that P-sel-Ig interacts with GSP-6', GSP-6" and GP-6 with weak, but similar affinity under reduced salt concentration (Figs. 4,5 ). We first determined the K d for binding of GP-6 to sPS at 50 mM NaCl concentration in equilibrium gel filtration (Fig. 6A) . The K d was 3.1 µM, which is ~40-fold lower than that of GSP-6 for sPS (K d ~ 76 nM) at subphysiological salt concentration (19) . The binding affinities of GSP-6' and GSP-6" for sPS were estimated relative to GP-6 using 500 pmol of sPS and subphysiological salt concentration in equilibrium gel filtration (Fig. 6B ). GSP-6' and GSP-6" bound to P-selectin with ~71% and ~53%, respectively, of the levels of GP-6 (Fig. 6C, inset) . The binding affinities of GSP-6', GSP-6" and GP-6 werẽ 1.7%, ~1.3% and ~2.5% relative to GSP-6, respectively (Fig. 6C) . In this assay, the binding of GSP-6' and GSP-6" to P-selectin was independent of sialic acid, because sialidase treatment of GSP-6' and GSP-6" did not affect binding (Fig. 6C, inset) . However, the binding of GSP-6' and GSP-6" to P-selectin was partially dependent on α1,3-fucosylation because nonfucosylated GSP-5' and GSP-5" showed reduced binding (Fig. 6C, inset) . Pronase-digested GP-6 did not detectably bind to sPS even at subphysiological salt concentration, showing that the C2-O-sLe Because sialylated PFPL was more abundant, it was postulated that the sialylated PFPL sequences in PSGL-1 may be particularly important for binding to P-selectin (10).
Additional indirect evidence in support of the importance of polylactosamine sequences for binding of PSGL-1 to P-selectin came from studies of the human α1,3-fucosyltransferases expressed in leukocytes, FucT-VII and FucT-IV, which differed in their ability to fucosylate polylactosamine sequences on synthetic acceptors in vitro (14, 15, 30) . FucT-IV acts preferentially on internal GlcNAc residues distal from the non-reducing terminus, whereas FucT-VII acts preferentially on the GlcNAc residue at the extreme non-reducing terminal sialylated Nacetyllactosamine unit. These results suggest that biosynthesis of the sialylated PFPL sequence might occur through the cooperative action of these two enzymes. The possibility that both enzymes are required to produce an optimal ligand for P-selectin was strengthened in studies in mice containing null mutations in either FucT-VII (17) or both FucT-VII and FucT-IV (16, 31) .
Deletion of FucT-VII alone dramatically reduced, but did not eliminate, binding of leukocytes to selectins, whereas deletion of both FucT-VII and FucT-IV totally eliminated binding. Such results were consistent with the proposal (10, 14, 16, 17 ) that a polylactosamine sequence modified by both FucT-VII and FucT-IV might be required for high affinity binding of PSGL-1 to Pselectin. However, the studies reported here indicate that such sialylated PFPL are not high affinity ligands for P-selectin.
Several studies have shown that singly fucosylated core 2-based O-glycans lacking PFPL on a tyrosine sulfated peptide modeled after PSGL-1 bind with high affinity to P-selectin (11, 19, 32) . The crystal structure of a recombinantly-derived glycosulfopeptide containing a disialylated, monofucosylated O-glycan and multiple TyrSO 3 -residues bound to the C-type lectin domain of human P-selectin revealed interactions with the single fucose and the sialic acid residue within the sLe x moiety plus interactions with the adjacent TyrSO 3 -residues and other flanking amino acids (32) .
The GSP-6" containing sialylated PFPL is probably too large to allow accommodation of both the fucose and sialic acid determinants and sulfated peptide determinants within the binding site of P-selectin, as depicted in Fig. 8 . It is likely that the terminal sialic acid and fucose residues in the sLe x at the non-reducing end of the sialylated PFPL O-glycans are extended far from the peptide and thus not in close proximity to the required TyrSO 3 -residues and flanking amino acids. Our results indicate that the weak binding of GSP-6" to P-selectin is not dependent on sialic acid, but is dependent on fucose and sulfated tyrosine residues. Thus, it is likely that the weak binding observed results from interactions shown in Fig. 8B , rather than Fig. 8C . The predicted model in Fig. 8B is also consistent with the slightly better binding observed for GSP-6' compared to GSP-6" to P-selectin (Fig. 7) . This may occur because of the sialic acid moiety in GSP-6' is closer to the peptide and fucose determinants than seen for the sialic acid in GSP-6". However, it is also possible that PSGL-1 may occur in various glycoforms, with some glycoforms of PSGL-1 containing sialylated PFPL at Thr57, thus promoting binding to Lselectin. To address such possibilities in the future, it will be necessary to evaluate the binding of L-selectin to all the modifications of the GSPs described to date.
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PSGL-1 also binds to E-selectin (13, 38, 39) and contributes significantly to the initial tethering of flowing leukocytes to E-selectin (40) , but the nature of the glycan ligands of PSGL-1
recognized by E-selectin are poorly understood. E-selectin appears to bind better to glycans containing PFPL than to short glycans (41) (42) (43) . Thus, E-selectin might bind preferentially to the sialylated PFPL O-glycans of PSGL-1. The polylactosamine sequences on PSGL-1 may also serve as a precursor to other modifications. Sulfated polylactosamine chains on PSGL-1, recognized as the PEN5 epitope, have been reported on PSGL-1 on some natural killer cells and in the human and rat central nervous systems (44, 45) . It is also possible that the sialylated PFPL glycans on PSGL-1 could interact with as yet unidentified lectins. For example, the human granulocytic ehrlichiosis bacterium binds in a sialic acid-and fucose-dependent manner to PSGL-1 on human neutrophils (46) , but the preferred glycans on PSGL-1 have not been defined.
The availability of the GSPs containing sialylated PFPL should allow these possibilities to be addressed.
The molecular interaction of glycosulfopeptides with P-selectin has many novel aspects.
The tripartite nature of the recognition involving carbohydrate, peptide determinants, and TyrSO 3 -promotes a high degree of specificity and high affinity. Sialic acid has an important role for binding of GSP-6 to P-selectin, since desialylation of GSP-6 reduces its binding to P-selectin by ~90% (19) . However, the binding of GSP-6' and GSP-6" to P-selectin appears to be largely sialic acid independent. Desialylated GSP-6' binds to P-selectin with only ~ 20% lower affinity than GSP-6', and the binding of GSP-6" to P-selectin is sialic acid independent. This suggests that sLe x on an extended fucosylated polylactosamine backbone of GSP-6' and GSP-6" is displaced relative to the three TyrSO 3 -residues, preventing simultaneous binding of TyrSO 3 -residues and sLe x to the lectin domain of P-selectin. The internal Le x of GSP-6' and GSP-6" may 24 instead contribute to binding (Fig. 8) . The observation that desialylated GSP-6 interacts with Pselectin with higher affinity than desialylated GSP-6' and GSP-6" is intriguing. It is possible that conformational differences between terminal Le x in desialylated GSP-6 and internal Le x in GSP-6' and GSP-6" account for this observation. Our earlier results have shown that α1,3-fucose contributes more than α2,3-sialic acid to binding of GSP-6 to P-selectin (19) . Similarly, the present study indicates that fucose contributes more than sialic acid to binding of GSP-6' and GSP-6" to P-selectin (Fig. 6,7 ). Nonfucosylated GSP-5' and GSP-5" show weak residual binding to P-selectin both in the fluorescence-based solid phase assay ( Fig. 5 ) and in equilibrium gel filtration (Fig. 6 ). The sulfated peptide backbone likely contributes partly to binding of GSP-5'
and GSP-5" to P-selectin, because GSP-1 shows weak binding to P-selectin (Fig. 5 ). The present results indicate that binding of GSP-1 to P-selectin is largely Ca 2+ independent (Fig. 5) . The result is similar to other studies indicating that P-selectin binds to sulfatide, sulfoglucuronyl glycolipids and heparan sulfate in a Ca 2+ independent manner (26, 47, 48) . This is in agreement with the crystal structure of P-selectin complexed with a PSGL-1-derived glycosulfopeptide, which indicates that TyrSO 3 -residues bind in a Ca 2+ -independent manner to a site different from the Ca 2+ -containing carbohydrate-binding site in the lectin domain of P-selectin (32) . Our results also indicate that binding of nonsulfated GP-6 to P-selectin is Ca 2+ dependent (Fig. 5 ).
This study, which used some of the largest glycopeptides synthesized in vitro to date, explored two novel approaches for synthesis. In Approach I ( Fig. 2A) , the extension of the polylactosamine chain was performed using partially purified β1,3-GlcNAcT from human serum (49). Because serum β1,3-GlcNAcT does not extend the core-1 galactose (49), core-1 galactose was not protected before extension of the core-2 branch. However, Approach II (Fig. 2B ) uses recombinant (Nm)β1,3-GlcNAcT from Neisseria meningitidis lgtA (22) , which can extend 25 galactose from both core-1 and core-2 glycans (22) . Therefore the core-1 galactose was sialylated to prevent its extension before extension of the core-2 branch. The core-1 sialic acid was removed after the synthesis of the polylactosamine chain. An earlier study suggested that (Nm)β1,3-GlcNAcT from N. meningitidis lgtA cannot efficiently extend polylactosamine structures on simple oligosaccharide acceptors (22) . However, we found that (Nm)β1,3-
GlcNAcT acts efficiently on the core-2 branch of our glycopeptide acceptors. This suggests that the peptide part of the acceptor may induce the optimal conformation of the carbohydrate acceptor for the enzyme.
We developed a fluorescence-based solid phase assay to measure P-selectin binding to 
